MedPath

CAN-2109

Generic Name
CAN-2109

Intratumoral CAN2109 in Subjects With Solid Tumors

Phase 1
Recruiting
Conditions
Lymphoma
Solid Tumor
Interventions
First Posted Date
2024-03-27
Last Posted Date
2024-12-19
Lead Sponsor
Canwell Biotech Limited
Target Recruit Count
27
Registration Number
NCT06332430
Locations
🇨🇳

Sun Yat-Sen University Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath